The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 4 rounds in the feed, most often at Series B and in Biotech.
Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.
Venture capitalagentcapital.comRounds from 2023-03-22 to 2026-10-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
STAR Therapeutics They develop and provide antibody therapies for patients with serious diseases. | Funding round Verified against 1 of 9 sources | $200M | 2026-10-22 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series C |
| $85M |
| 2026-06-30 |
| [ PART ] |
GlycoEra Biologics aimed at precision immunology, targeting and degrading specific proteins associated with autoimmune diseases for improved patient outcomes. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $130M | 2025-05-27 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |